Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Operating activities:
Net loss	$ (32,769,000)	$ (396,000)
Adjustments to reconcile net loss to net cash provided by operating activities:
Deferred taxes	1,637,000	0
Amortization of stock-based compensation	1,110,000	1,089,000
Distributions of earnings from unconsolidated joint ventures	0	279,000
Inventory impairments	19,000,000	0
Project abandonment costs	14,130,000	19,000
Equity in net (income) loss of unconsolidated joint ventures	21,899,000	(369,000)
Depreciation and amortization	3,623,000	5,042,000
Gain on early extinguishment of debt	(579,000)	(969,000)
Net changes in operating assets and liabilities:
Contracts and accounts receivable	8,870,000	2,152,000
Due from affiliates	98,000	975,000
Real estate inventories	30,579,000	24,970,000
Other assets	(31,133,000)	(2,240,000)
Accounts payable	(8,932,000)	(12,762,000)
Accrued expenses and other liabilities	(5,510,000)	1,102,000
Net cash provided by operating activities	22,023,000	18,892,000
Investing activities:
Purchases of property and equipment	(143,000)	(8,000)
Contributions and advances to unconsolidated joint ventures	(3,847,000)	(4,120,000)
Distributions of capital and repayment of advances from unconsolidated joint ventures	2,370,000	4,928,000
Net cash (used in) provided by investing activities	(1,620,000)	800,000
Financing activities:
Borrowings from credit facility	0	40,000,000
Repayments of credit facility	0	(41,500,000)
Repurchases of senior notes	(9,825,000)	(10,856,000)
Proceeds from note payable	7,036,000	0
Repayment of note payable	(7,036,000)	0
Payment of debt issuance costs	(255,000)	0
Repurchases of common stock	(3,718,000)	(1,042,000)
Tax withholding paid on behalf of employees for stock awards	(304,000)	(488,000)
Net cash used in financing activities	(14,102,000)	(13,886,000)
Net increase in cash, cash equivalents and restricted cash	6,301,000	5,806,000
Cash, cash equivalents and restricted cash – beginning of period	79,431,000	42,542,000
Cash, cash equivalents and restricted cash – end of period	$ 85,732,000	$ 48,348,000